Company: JUPGF
Filing Date: 2025-10-08
Form Type: F-1/A
Source: 0001493152-25-017439
Chunk: 149

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-10-08
Form: F-1/A
Chunk 149
---
 A Preferred
holder.

For as long as there is
one share of the Series A Preferred outstanding, the holder of the Series A Preferred shall be entitled to nominate one director to our
Board of Directors.

As of the date of this
prospectus, only one share of our Series A Preferred has been issued and is outstanding, which share is held by Marc Fogassa, our Chairman
and Chief Executive Officer.

| 114 |

Undesignated Preferred Stock

As of the date of this
prospectus, our Board of Directors has the authority to issue up to 9,999,999 additional shares of preferred stock in one or more series
and fix the number of shares constituting any such series, the voting powers, designations, preferences and relative, participating,
optional or other special rights and qualifications, limitations or restrictions thereof, including the dividend rights, dividend rate,
terms of redemption (including sinking fund provisions), redemption price or prices, conversion rights and liquidation preferences of
the shares constituting any series, without any further vote or action by the stockholders. For example, the Board of Directors is authorized
to issue preferred stock that would have the right to vote, separately or with any other stockholder of preferred stock, on any proposed
amendment to our certificate of incorporation, or on any other proposed corporate action, including business combinations and other transactions.

We will not offer preferred
stock unless the offering is approved by a majority of our independent directors. The independent directors will have access, at our
expense, to our counsel or independent counsel.

Options and Warrants

As of the date of this prospectus, options and warrants to purchase up to 203,352 shares of our common stock (already reflecting the Reverse Stock Split) were issued and outstanding, with a weighted-average time of exercise of 3.48 years, and a weighted-average exercise price of $1.08.

As of the date of this prospectus, the Company does not have any outstanding warrants to purchase shares of our common stock.

Equity Awards

During the year ended December
31, 2024, the Company granted Mr. Fogassa as contractual compensation options to purchase an aggregate of 42,000 shares of its
common stock (account for the reverse stock split). The options issued in 2024 were valued at $41,938 in total. The options were valued
using the Black-Scholes option pricing model with the following average assumptions: our stock price on date of grant $3.70 to